These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24334261)

  • 21. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case control study of diffusion tensor imaging in Parkinson's disease.
    Chan LL; Rumpel H; Yap K; Lee E; Loo HV; Ho GL; Fook-Chong S; Yuen Y; Tan EK
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1383-6. PubMed ID: 17615165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
    Hope TR; Selnes P; Rektorová I; Anderkova L; Nemcova-Elfmarkova N; Balážová Z; Dale A; Bjørnerud A; Fladby T
    PLoS One; 2019; 14(5):e0217922. PubMed ID: 31150514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.
    Ofori E; Krismer F; Burciu RG; Pasternak O; McCracken JL; Lewis MM; Du G; McFarland NR; Okun MS; Poewe W; Mueller C; Gizewski ER; Schocke M; Kremser C; Li H; Huang X; Seppi K; Vaillancourt DE
    Mov Disord; 2017 Oct; 32(10):1457-1464. PubMed ID: 28714593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson's disease: A diagnostic performance study and meta-analysis.
    Hirata FCC; Sato JR; Vieira G; Lucato LT; Leite CC; Bor-Seng-Shu E; Pastorello BF; Otaduy MCG; Chaim KT; Campanholo KR; Novaes NP; Melo LM; Gonçalves MR; do Nascimento FBP; Teixeira MJ; Barbosa ER; Amaro E; Cardoso EF
    Eur Radiol; 2017 Jun; 27(6):2640-2648. PubMed ID: 27709279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course study of fractional anisotropy in the substantia nigra of a parkinsonian rat model induced by 6-OHDA.
    Zhang W; Zhang L; Liu L; Wang X
    Behav Brain Res; 2017 Jun; 328():130-137. PubMed ID: 28390876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions.
    Unger MM; Belke M; Menzler K; Heverhagen JT; Keil B; Stiasny-Kolster K; Rosenow F; Diederich NJ; Mayer G; Möller JC; Oertel WH; Knake S
    Sleep; 2010 Jun; 33(6):767-73. PubMed ID: 20550017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study.
    Menke RA; Scholz J; Miller KL; Deoni S; Jbabdi S; Matthews PM; Zarei M
    Neuroimage; 2009 Aug; 47(2):435-41. PubMed ID: 19447183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Parkinson's disease: diffusion kurtosis imaging and the correlation with clinical manifestations].
    Sun YQ; Zhang Q; Jiang Z; Zhang CY; Zhang JW; Chen H; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3534-3537. PubMed ID: 29275590
    [No Abstract]   [Full Text] [Related]  

  • 30. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.
    Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C
    Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.
    Schuff N; Wu IW; Buckley S; Foster ED; Coffey CS; Gitelman DR; Mendick S; Seibyl J; Simuni T; Zhang Y; Jankovic J; Hunter C; Tanner CM; Rees L; Factor S; Berg D; Wurster I; Gauss K; Sprenger F; Seppi K; Poewe W; Mollenhauer B; Knake S; Mari Z; McCoy A; Ranola M; Marek K
    Mov Disord; 2015 Dec; 30(14):1885-92. PubMed ID: 26260437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nigral MRI features of asymptomatic welders.
    Lee EY; Flynn MR; Du G; Lewis MM; Goldenberg M; Kong L; Mailman RB; Hong YS; Huang X
    Parkinsonism Relat Disord; 2021 Apr; 85():37-43. PubMed ID: 33691274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
    Esterhammer R; Seppi K; Reiter E; Pinter B; Mueller C; Kremser C; Zitzelsberger T; Nocker M; Scherfler C; Poewe W; Schocke M
    PLoS One; 2015; 10(12):e0145493. PubMed ID: 26713760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson's Disease.
    Pelizzari L; Laganà MM; Di Tella S; Rossetto F; Bergsland N; Nemni R; Clerici M; Baglio F
    Front Aging Neurosci; 2019; 11():134. PubMed ID: 31214017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
    Wang C; Fan G; Xu K; Wang S
    Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid PET-MRI for early detection of dopaminergic dysfunction and microstructural degradation involved in Parkinson's disease.
    Shang S; Li D; Tian Y; Li R; Zhao H; Zheng L; Zhang Y; Chen YC; Yin X
    Commun Biol; 2021 Oct; 4(1):1162. PubMed ID: 34621005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.
    Bergsland N; Zivadinov R; Schweser F; Hagemeier J; Lichter D; Guttuso T
    Mov Disord; 2019 Jul; 34(7):1006-1013. PubMed ID: 31180615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia.
    Su D; Gan Y; Zhang Z; Cui Y; Zhang Z; Liu Z; Wang Z; Zhou J; Sossi V; Stoessl AJ; Wu T; Jing J; Feng T
    Mov Disord; 2023 Apr; 38(4):616-625. PubMed ID: 36799459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra.
    Zhong Z; Merkitch D; Karaman MM; Zhang J; Sui Y; Goldman JG; Zhou XJ
    Radiology; 2019 Apr; 291(1):149-157. PubMed ID: 30777809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.